SCHEMBL6473241

SCHEMBL6473241

COc1ccc(-c2nc(-c3cc(C(=O)O)c(C)n3CCCN3CCCCC3)cs2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATP4A P20648 4/20 0.50
ATP4B P51164 4/20 0.50
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 3/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ACHE P22303 1/20 0.46
MAPT P10636 3/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
CRHBP P24387 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
CRHR2 Q13324 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 2/20 0.43
HPGD P15428 1/20 0.43
MC4R P32245 1/20 0.43
CDC25A P30304 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039541 0.87 KDM4E (0.52) ATP4AATP4BALDH1A1KDM4ENPC1
SCHEMBL5049091 0.87 ALDH1A1 (0.53) ATP4AATP4BALDH1A1NPC1RAB9A
SCHEMBL6472891 0.87 ALDH1A1 (0.48) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL5044308 0.87 ALDH1A1 (0.54) ATP4AATP4BALDH1A1KDM4ENPC1
SCHEMBL5044535 0.85 ALDH1A1 (0.53) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL6877086 0.84 ALDH1A1 (0.47) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL6882157 0.84 KDM4E (0.48) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL6879680 0.83 KDM4E (0.51) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL5045711 0.82 KDM4E (0.55) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL5039301 0.82 CDC25A (0.49) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed